eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
3/2020
vol. 71
 
Share:
Send email
Share:
abstract:
Original paper

The value of BAP1 immunocytochemistry and CDKN2A fluorescence in situ hybridization in diagnosis of serous effusion malignant mesothelioma and an analysis of the association between degree of cell atypia and the results of two auxiliary methods

Wenhao Ren
1
,
Lin-lin Zhao
1
,
Lei Guo
1
,
Ning Lu
1
,
Jian Cao
1, 2

  1. Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  2. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Pol J Pathol 2020; 71 (3): 229-235
DOI: https://doi.org/10.5114/pjp.2020.99789
Online publish date: 2020/10/25
View full text Get citation
 
PlumX metrics:
Malignant mesothelioma (MM) is a rare, highly aggressive tumor. The first symptom of MM is mostly serous effusion, and cytology can be used in diagnosis based on effusion, providing patients with an earlier diagnosis and treatment opportunity.

A total of 67 specimens were embedded into cell blocks, and BAP1 immunocytochemistry (ICC) was performed. CDKN2A fluorescence in situ hybridization (FISH) was performed in 45 cases. The sensitivity, specificity and the association between the degree of cell atypia and the results of two auxiliary methods were analyzed.

BAP1 ICC showed nonexpression in 13 of 24 cases of MM and 0 of 21 cases of benign mesothelial proliferation (BMP). The sensitivity was 54.2% (13/24), and the specificity was 100% (21/21). In addition, 22 metastatic adenocarcinoma (MA) cases all showed BAP1 expression. MM with BAP1 expression had more obvious cell atypia. CDKN2A deletion was found in 12 of 24 MM cases and 0 of 21 BMP cases. The sensitivity was 50% (12/24), and the specificity was 100% (21/21). BAP1 ICC and CDKN2A FISH are useful methods to differentiate MM from BMP. The cell atypia of MM with BAP1 expression was more obvious than MM with BAP1 nonexpression.
keywords:

malignant mesothelioma, immunocytochemistry, fluorescence in situ hybridization, BAP1, CDKN2A
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.